September 17 - 18, 2009, The Hub CHF Conference Center, Philadelphia, PA
Download the 2009 Agenda.
Discussing Biomarker Innovations with Dr. Richard Kennedy, VP, Experimental Medicine, Almac Diagnostics
Become a Pharma IQ Member and receive our monthly newsletter!
Learn more about sponsor & exhibit opportunities
Webcasts
Biomarkers have become one of the most important tools to detect and monitor disease progressions and they have been playing important roles in cancer diagnostics, treatments and drug development.
Pharmaceutical and biotech companies are putting tremendous effort in the research of the discovery and management of biomarkers; however, there is a lot to be done on the qualification, validation and applications of the biomarkers. The impact of the biomarkers on the pharmacology is yet to be discovered.
Cutting-edge technologies of Proteomics, Genomics and Imaging will be presented. Practical case studies coupled with recent regulatory updates and their impact on the applications are making this event a great learning opportunity that you don’t want to miss!
VPs / Directors / Heads of:
From Pharmaceutical, Biotech and Cancer Research Institutions
[ Register Now ]